Apogee Therapeutics (APGE) Stock Forecast, Price Target & Predictions
APGE Stock Forecast
Apogee Therapeutics stock forecast is as follows: an average price target of $95.00 (represents a 99.12% upside from APGE’s last price of $47.71) and
APGE Price Target
Apogee Therapeutics Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 13, 2024 | Alex Thompson | Stifel Nicolaus | $95.00 | $52.71 | 80.23% | 99.12% |
The latest Apogee Therapeutics stock forecast, released on May 13, 2024 by Alex Thompson from Stifel Nicolaus, set a price target of $95.00, which represents a 80.23% increase from the stock price at the time of the forecast ($52.71), and a 99.12% increase from APGE last price ($47.71).
Apogee Therapeutics Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $95.00 |
| Last Closing Price | $47.71 | $47.71 | $47.71 |
| Upside/Downside | -100.00% | -100.00% | 99.12% |
In the current month, the average price target of Apogee Therapeutics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Apogee Therapeutics's last price of $47.71. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Apogee Therapeutics Financial Forecast
Apogee Therapeutics Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| # Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Apogee Therapeutics's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. APGE's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Apogee Therapeutics EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
undefined analysts predict APGE's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Apogee Therapeutics's previous annual EBITDA (undefined) of $NaN.
Apogee Therapeutics Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-65.71M | $-64.82M | $-62.20M | $-60.51M | $-59.33M | $-58.18M | $-57.04M | $-55.92M | $-60.71M | $-53.14M | $-56.14M | $-48.99M | $-61.15M | $-49.92M | $-33.81M |
| High Forecast | $-65.71M | $-64.82M | $-62.20M | $-60.51M | $-59.33M | $-58.18M | $-57.04M | $-55.92M | $-60.71M | $-53.14M | $-56.14M | $-48.99M | $-54.65M | $-49.92M | $-33.81M |
| Low Forecast | $-65.71M | $-64.82M | $-62.20M | $-60.51M | $-59.33M | $-58.18M | $-57.04M | $-55.92M | $-60.71M | $-53.14M | $-56.14M | $-48.99M | $-63.76M | $-49.92M | $-33.81M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Apogee Therapeutics's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. APGE's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Apogee Therapeutics SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Apogee Therapeutics's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to APGE last annual SG&A of $NaN (undefined).
Apogee Therapeutics EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-1.16 | $-1.14 | $-1.10 | $-1.07 | $-1.04 | $-1.02 | $-1.00 | $-0.98 | $-1.07 | $-0.94 | $-0.99 | $-0.86 | $-1.08 | $-0.88 | $-0.60 |
| High Forecast | $-1.16 | $-1.14 | $-1.10 | $-1.07 | $-1.04 | $-1.02 | $-1.00 | $-0.98 | $-1.07 | $-0.94 | $-0.99 | $-0.86 | $-0.96 | $-0.88 | $-0.60 |
| Low Forecast | $-1.16 | $-1.14 | $-1.10 | $-1.07 | $-1.04 | $-1.02 | $-1.00 | $-0.98 | $-1.07 | $-0.94 | $-0.99 | $-0.86 | $-1.12 | $-0.88 | $-0.60 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Apogee Therapeutics's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to APGE previous annual EPS of $NaN (undefined).